Skip to content
logo-orbit-white
Main Menu
  • Training Courses
    • RRI Training
    • Trusted Research
    • Design of Ethical AI Systems
    • Stakeholder Engagement
    • Data Governance
    • Ethical Hackathons
    • Responsible Quantum Technologies
    • Environmentally Sustainable Research
  • Resources & Tools
    • AREA 4P Framework
    • The Keys of RRI
    • About RRI Maturity
    • Self Assessment Tool
    • Self Assessment Results
    • RRI Maturity
    • RRI Maturity Results
    • Action Plan
    • Action Plan Results
  • Services
  • News
  • Contact
Login

RRI Training

I

Trusted Research Training

I

Ethical AI Systems Training

I

Stakeholder Engagement

I

Data Governance

I

Sustainable Research

  • About ORBIT
    • AREA 4P Framework
    • The Keys of RRI
    • Employment Opportunities
  • Tools
  • Contact
  • Account
    • Workshop Hub
    • Your Courses
    • Organisation RRI Maturity Archive
    • RRI Intensity Level Archive
    • Your Action Plans
    • Delete Your Account
  • Embrace Course Booking
  • Journal
  • Toggle website search
Read more about the article Engineered Bacteria Transforming Plastic Waste into a Parkinson’s Disease Treatment

Engineered Bacteria Transforming Plastic Waste into a Parkinson’s Disease Treatment

Recent advancements at the University of Edinburgh have showcased a remarkable innovation in biotechnology, where engineered bacteria have been utilised to convert common PET plastic waste into L-DOPA, an essential…

Read more about the article Excalipoint Secures $68.7 Million to Advance T-Cell Engager Platforms

Excalipoint Secures $68.7 Million to Advance T-Cell Engager Platforms

Excalipoint has successfully raised $68.7 million to further its development of T-cell engagers, a promising area in biotechnology. This funding comprises a $41 million seed round initiated at the company’s…

Read more about the article Journey Medical Corporation to Release Year-End 2025 Financial Results on March 25, 2026

Journey Medical Corporation to Release Year-End 2025 Financial Results on March 25, 2026

SCOTTSDALE, Ariz., March 18, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation ('Journey Medical' or the 'Company') (Nasdaq: DERM), a commercial-stage pharmaceutical company focused on the marketing and sale of U.S.…

Read more about the article Agilisium’s Strategic Investment in AI to Transform Life Sciences Sector

Agilisium’s Strategic Investment in AI to Transform Life Sciences Sector

Agilisium has announced a significant investment of Rs 50 crore aimed at revolutionising the life sciences sector by facilitating the operationalisation of artificial intelligence (AI) within pharmaceutical, biotech, and medical…

Read more about the article Initiative Launched to Foster Entrepreneurial Talent in Semiconductors, Quantum Technologies, and Bio-Convergence

Initiative Launched to Foster Entrepreneurial Talent in Semiconductors, Quantum Technologies, and Bio-Convergence

Photo credit: Hanna Teib for Israel Innovation Authority The Israel Innovation Authority has announced a significant investment of NIS 10 million to support the development of new training programmes aimed…

Read more about the article Validation of ALZpath’s pTau217 Antibody at AD/PD™ 2026: A Benchmark for Blood-Based Alzheimer’s Diagnostics

Validation of ALZpath’s pTau217 Antibody at AD/PD™ 2026: A Benchmark for Blood-Based Alzheimer’s Diagnostics

Data Presented Across 29 Sessions Highlights Precision, Accessibility and Platform-Agnostic Adoption, Establishing pTau217 as a Leading Blood-Based Biomarker CARLSBAD, Calif., March 17, 2026 /PRNewswire/ -- ALZpath, Inc., a prominent entity…

Read more about the article Dimension Venture Capital Firm Seeks $700 Million for New Fund

Dimension Venture Capital Firm Seeks $700 Million for New Fund

Dimension, a notable venture capital firm, is in the process of raising its third fund, with aspirations to secure approximately $700 million. This new fund aims to invest in enterprises…

Read more about the article Niagen Bioscience Launches Innovative Waterless NAD+ Skincare Solution

Niagen Bioscience Launches Innovative Waterless NAD+ Skincare Solution

Key Insights Niagen Bioscience has unveiled its Skincare Innovation Lab, a pioneering initiative aimed at transforming supplement science into topical skincare innovations. The inaugural product from this lab is NanoCloud,…

Read more about the article Ulrich Wendt Appointed Chief Business Officer at Alchemab Therapeutics to Enhance Biopharma Collaborations

Ulrich Wendt Appointed Chief Business Officer at Alchemab Therapeutics to Enhance Biopharma Collaborations

CAMBRIDGE, England--(BUSINESS WIRE)--Mar 17, 2026-- Alchemab Therapeutics, a prominent player in the UK biotechnology sector, has announced the appointment of Ulrich Wendt as its new Chief Business Officer. This strategic…

Read more about the article Structure Therapeutics Advances GLP-1 Drug Development for Weight Management

Structure Therapeutics Advances GLP-1 Drug Development for Weight Management

Structure Therapeutics is making significant strides in the development of new GLP-1 medications aimed at assisting individuals in weight management. This innovative biotech firm, among several others in the sector,…

  • Go to the previous page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 14
  • Go to the next page

Course Information

Help & Information

  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact
  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact

Contact Us

  • contact@orbit-rri.org
  • @orbitrri
  • @orbitrri

Training & Workshops

AI Empowerment

Stakeholder Engagement

Trusted Research

Data Governance

Ethical Hackathons

RRI Training

Responsible Quantum Technologies

Environmentally Sustainable Research

Design of Ethical AI Systems

  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact
Copyright 2023 - ORBIT RRI a not for profit company.

By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Accept